The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

During clinical trials, it became apparent that patients were experiencing significant weight loss. This discovery has led to ...

Eli Lilly said on Monday it sued three medical spas and online vendors for selling products claiming to contain tirzepatide, ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

Ozempic, a popular drug for treating diabetes and promoting weight loss, has emerged as an unexpected weapon in the fight ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...

The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...

Weight loss drugs have risen in popularity in the recent years, but a disconnect remains between those who need the drugs and ...

The injections led to a 50% lower rate of alcohol intoxication in people taking them compared to those who had not been ...

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.